Shooting for the moon: The case for early colorectal cancer screening
Permanente oncologist leader Tatjana Kolevska, MD, shares important takeaways from the recent White House Cancer Moonshot Colorectal Cancer Forum.
Permanente oncologist leader Tatjana Kolevska, MD, shares important takeaways from the recent White House Cancer Moonshot Colorectal Cancer Forum.
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
APCCC 2024 global access of advanced prostate cancer, Prostate cancer incidence, radical prostatectomy, pidemiological differences of prostate cancer between China and the United States.
APCCC 2024 how to identify aggressive variant prostate cancer, Castrate-resistant prostate cancer, aggressive variant prostate cancer, neuroendocrine prostate cancer, SPOP alterations.
APCCC 2024 promise and pitfalls of social media and artificial intelligence for prostate cancer, Lancet Commission on Prostate Cancer,
APCCC 2024, alternative PSMA Ligands, 68Ga-PSMA-11, 18F-DCFPyL, 18F-PSMArh7.3, 18F-PSMA-1007, benign bone uptake, PSMA-617, PSMA-I&T, SPOTLIGHT trial, 18F-PSMArh7.33, UCLA/UCSF trial, CONDOR trial.
APCCC 2024, metastatic castration resistant prostate cancer (mCRPC), PSMA radioligand therapy, Docetaxel, cabazitaxel, 177Lu-PSMA-617, TROPIC trial, CARD trial, TAX327 trial, SWOG 9916 trial, PRESIDE trial,…
At the 2024 UCSF-UCLA PSMA Conference, Oliver Sartor advocates for the early use of PSMA radioligand therapy in prostate cancer treatment, challenging the traditional reliance…
Were you unable to attend APCCC 2024? Get all of the groundbreaking research, new guidelines, and the latest advances in urologic medicine you missed.
APCCC 2024, prostate cancer, Lancet Commission on Prostate Cancer, prostate cancer population, worldwide prostate cancer cases, prostate cancer future outlook, global prostate cancer disparity.